INOVIO PHARMACEUTICALS, INC. - INO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 4.0% | 3,428,571 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 4.0% | 3,428,571 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 4.0% | 3,428,571 | View |
| Aug 07, 2026 | SCHEDULE 13G | RA Capital Management, L.P. | 9.9% | 10,666,523 | View |
| Aug 07, 2026 | SCHEDULE 13G | Peter Kolchinsky | 9.9% | 10,666,523 | View |
| Aug 07, 2026 | SCHEDULE 13G | Rajeev Shah | 9.9% | 10,666,523 | View |
| Aug 07, 2026 | SCHEDULE 13G | RA Capital Healthcare Fund, L.P. | 9.9% | 10,666,523 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | FMR LLC | 10.3% | 8,454,797 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 10.3% | 8,454,797 | View |
| Jul 31, 2026 | SCHEDULE 13G | Vanguard Capital Management | 5.05% | 4,161,566 | View |
| May 15, 2026 | SCHEDULE 13G/A | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.2% | 6,190,475 | View |
| May 13, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.84% | 4,233,529 | View |
| May 13, 2026 | SCHEDULE 13G/A | Robert Atchinson | 5.84% | 4,233,529 | View |
| May 13, 2026 | SCHEDULE 13G/A | Phillip Gross | 5.84% | 4,233,529 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 13.5% | 9,339,614 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 13.5% | 9,339,614 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.